Health and Fitness Health and Fitness
Wed, September 29, 2010
[ Wed, Sep 29th 2010 ] - Market Wire
Electromed Announces Exercise of Over-allotment Option
[ Wed, Sep 29th 2010 ] - Market Wire
Atrium Innovations to Present at Upcoming Jefferi .. bal SpecPharma and European Healthcare Conference
[ Wed, Sep 29th 2010 ] - Market Wire
Northstar Healthcare Shareholders Approve Private Placement
[ Wed, Sep 29th 2010 ] - Market Wire
ZIOPHARM Oncology to Present at the 9th Annual BIO Investor Forum
[ Wed, Sep 29th 2010 ] - Market Wire
Health Net Federal Services Partners with Nashvil .. chael, to Promote the Behavioral Health of Milita
[ Wed, Sep 29th 2010 ] - Market Wire
Apricus Bio Announces Pricing of Securities Offering
[ Wed, Sep 29th 2010 ] - Market Wire
CPEX Announces Continuation of Strategic Alternatives Review Process
[ Wed, Sep 29th 2010 ] - Market Wire
Progenics Announces Approvals of New Ready-to-Use .. ed Syringes for RELISTOR in U.S., E.U. and Canada
[ Wed, Sep 29th 2010 ] - Market Wire
Zalicus to Present Corporate Updates in October
[ Wed, Sep 29th 2010 ] - Market Wire
Alnylam Publishes Results from Phase IIa Study of .. f Respiratory Syncytial Virus Infection in Lung T
[ Wed, Sep 29th 2010 ] - Market Wire
YM BioSciences licensee Pulmokine awarded NIH fun .. p small molecule drugs for pulmonary hypertension
[ Wed, Sep 29th 2010 ] - Market Wire
CENTRIC HEALTH ESTABLISHES PHARMACY DIVISION
[ Wed, Sep 29th 2010 ] - Market Wire
Covidien plc pubblicher i risultati del quarto trimestre il 9 novembre 2010
[ Wed, Sep 29th 2010 ] - Market Wire
Covidien plc gibt Ergebnisse des vierten Quartals am 9. November 2010 bekannt
[ Wed, Sep 29th 2010 ] - Market Wire
Covidien plc pr©sentera ses r©sultats du quatrime trimestre le 9 novembre 2010
[ Wed, Sep 29th 2010 ] - Market Wire
Quidel Announces FDA Clearance of Its QuickVue® RSV 10 Immunoassay Diagnostic Test
[ Wed, Sep 29th 2010 ] - Market Wire
Covidien plc Divulgar Resultados do Quarto Trimestre em 9 de Novembro de 2010
[ Wed, Sep 29th 2010 ] - Market Wire
Covidien plc presentar los resultados correspondi .. tes al cuarto trimestre el 9 de noviembre de 2010
[ Wed, Sep 29th 2010 ] - Market Wire
Covidien plc to Report Fourth-Quarter Results on November 9, 2010
[ Wed, Sep 29th 2010 ] - Market Wire
BD Diagnostics and Bruker Collaborate to Improve .. fication and Antimicrobial Susceptibility Testing
[ Wed, Sep 29th 2010 ] - Market Wire
Wellstar International, Inc. Announces the Result .. n of the Duke University Study Have Been Accepted
Tue, September 28, 2010
[ Tue, Sep 28th 2010 ] - Market Wire
Prospect Medical Holdings, Inc. Announces End of aGo-Shopa Period
[ Tue, Sep 28th 2010 ] - Market Wire
Medtronic Advances Research on Drug-Eluting Balloons for Coronary and Peripheral Artery Disease
[ Tue, Sep 28th 2010 ] - Market Wire
HealthSpring, Inc. Announces the Addition of John T. Fox to Its Board of Directors
[ Tue, Sep 28th 2010 ] - Market Wire
Medtronica?s Insertable Cardiac Monitor Documented Arrhythmias in Post-Heart Attack Patients
[ Tue, Sep 28th 2010 ] - Market Wire
Covidien far Apresentao na conferncia "Jefferies European Healthcare Conference"
[ Tue, Sep 28th 2010 ] - Market Wire
Aetna Becomes First Georgia Insurer to Cover Medically Fragile Children for aDream Housea?
[ Tue, Sep 28th 2010 ] - Market Wire
Nicusa Capital Calls for Leadership Changes at BioClinica
[ Tue, Sep 28th 2010 ] - Market Wire
Synergetics USA to Present at Craig-Hallum Capital Group 2010 Alpha Select Conference
[ Tue, Sep 28th 2010 ] - Market Wire
Covidien presenteert tijdens congres Jefferies European Healthcare

Covidien presenteert tijdens congres Jefferies European Healthcare


Published on 2010-09-28 08:00:50 - Market Wire
  Print publication without navigation


MANSFIELD, Mass.--([ BUSINESS WIRE ])--Covidien (NYSE: COV) houdt een presentatie tijdens het Jefferies 2010 Global SpecPharma and European Healthcare Conference op 5 oktober 2010 gehouden in Londen. Coleman N. Lannum, vice-president van de divisie Investor Relations, bespreekt het reilen en zeilen van het bedrijf. De live radiowebzending van deze presentatie is toegankelijk vanaf de Investor Relations website van Covidien, http://investor.covidien.com. Covidien is een vooraanstaand internationaal bedrijf op het gebied van producten voor de gezondheidszorg die innovatieve medische oplossingen ontwikkelt voor betere resultaten voor de patint en waarde biedt via klinisch leiderschap en uitmuntendheid. Covidien produceert, distribueert en onderhoudt een divers scala van brancheleidende productlijnen.

Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal welke als enige juridische geldigheid beoogt.

Contributing Sources